All Stories

  1. A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression
  2. Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2)
  3. It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies
  4. Front Cover: Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index (ChemMedChem 11/2025)
  5. Cover Feature: Advances in Diclofenac Derivatives: Exploring Carborane‐Substituted N‐Methyl and Nitrile Analogs for Anticancer Therapy (ChemMedChem 11/2025)
  6. Deciphering the Tumor Uptake of Heterobivalent (SST2/Albumin) [64Cu]Cu-NODAGA-cLAB-TATEs
  7. Development of [99mTc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer
  8. Carborane‐based Analogues of Celecoxib and Flurbiprofen, their COX Inhibition Potential and COX Selectivity Index
  9. Advances in Diclofenac Derivatives: Exploring Carborane‐Substituted N‐Methyl and Nitrile Analogs for Anti‐Cancer Therapy
  10. Exploring a Nitric Oxide-Releasing Celecoxib Derivative as a Potential Modulator of Bone Healing: Insights from Ex Vivo and In Vivo Imaging Experiments
  11. Front Cover: Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity (ChemMedChem 1/2025)
  12. Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential
  13. Towards more reliable experimental models for pancreatic cancer
  14. Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In
  15. Programmable Release of Chemotherapeutics from Ferrocene‐Based Injectable Hydrogels Slows Melanoma Growth
  16. Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity
  17. 64 Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates
  18. Impact of Viscosity on Human Hepatoma Spheroids in Soft Core–Shell Microcapsules
  19. Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2
  20. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments
  21. Towards an advanced clinical use of radiocopper in cancer theranostics
  22. Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma
  23. Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging
  24. Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis
  25. Comparative Saturation Binding Analysis of 64Cu-Labeled Somatostatin Analogues Using Cell Homogenates and Intact Cells
  26. Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs
  27. Reactivating damaged motor neurons using magnetic fields
  28. Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
  29. Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents
  30. Carborane‐based Tebufelone Analogs and their Biological Evaluation In Vitro
  31. Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
  32. Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses
  33. Shell engineering in soft alginate‐based capsules for culturing liver spheroids
  34. Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins
  35. A self-assembled dynamic extracellular matrix-like hydrogel system with multi-scale structures for cell bioengineering applications
  36. Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
  37. Microdialysis Reveals Anti-Inflammatory Effects of Sulfated Glycosaminoglycanes in the Early Phase of Bone Healing
  38. Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
  39. Prostaglandins and the Lung
  40. The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2
  41. Modulating the Renal Clearance of Targeted Radiopharmaceuticals
  42. Carborane-based Compounds in Dual Inhibitor Design
  43. Pheochromocytoma radionuclide theranostics and radiation transcriptomics
  44. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity
  45. Impact of Sulfated Hyaluronan on Bone Metabolism in Diabetic Charcot Neuroarthropathy and Degenerative Arthritis
  46. Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225
  47. Targeting neuropeptide receptors for cancer imaging
  48. New link between dietary phosphate and coronary heart disease
  49. NO• donors in cancer therapy
  50. Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome
  51. Better understanding the metabolic stability of radiotracers
  52. Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation
  53. Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates
  54. The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells
  55. Acceleration to the next level
  56. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
  57. CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells
  58. A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries
  59. Targeting estrogen receptors in melanoma
  60. Targeting bone with copper radionuclides
  61. “Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals
  62. Solid-Phase Synthesis of Selectively Mono-Fluorobenz(o)ylated Polyamines as a Basis for the Development of 18F-Labeled Radiotracers
  63. Hybrid agents for multimodal imaging
  64. Men who stare at bone: multimodal monitoring of bone healing
  65. Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics
  66. Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
  67. Conductive Hydrogels with Dynamic Reversible Networks for Biomedical Applications
  68. Immunocompatibility and non-thrombogenicity of gelatin-based hydrogels
  69. Convergent synthesis of diversified reversible network leads to liquid metal-containing conductive hydrogel adhesives
  70. Development of an 18F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues
  71. Development of a ghrelin receptor inverse agonist for positron emission tomography
  72. The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease
  73. Response of Endothelial Cells to Gelatin-Based Hydrogels
  74. Pseudohypoxia causes radioresistance
  75. Screening Arrays of Laminin Peptides on Modified Cellulose for Promotion of Adhesion of Primary Endothelial and Neural Precursor Cells
  76. A modular, injectable, non-covalently assembled hydrogel system features widescale tunable degradability for controlled release and tissue integration
  77. The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts
  78. The influence of different artificial extracellular matrix implant coatings on the regeneration of a critical size femur defect in rats
  79. Pseudohypoxia promotes metastasis
  80. Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging
  81. Radiopharmaceutical Cancer Research goes 3D
  82. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
  83. Fighting Cancer: Targeting the Eph Receptor Tyrosine Kinase Subfamily
  84. Comparison of manual and automated ventricle segmentation in the maternal immune stimulation rat model of schizophrenia
  85. The sigma-1 receptor: Potential role in the modulation of cellular radiation sensitivity
  86. Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches
  87. Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
  88. Regulation of bone regeneration
  89. Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation
  90. Adjuvant drug-assisted bone healing: Part II – Modulation of angiogenesis
  91. Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation
  92. Synthesis, radiolabelling and initial biological characterisation of 18F-labelled xanthine derivatives for PET imaging of Eph receptors
  93. Deuteration versus ethylation – strategies to improve the metabolic fate of an 18F-labeled celecoxib derivative
  94. Fluorescent mouse pheochromocytoma spheroids expressing hypoxia-inducible factor 2 alpha: Morphologic and radiopharmacologic characterization
  95. Active Targeting of Dendritic Polyglycerols for Diagnostic Cancer Imaging
  96. Bone healing made visible
  97. Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs
  98. Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician
  99. Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials
  100. A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
  101. Radiochemical and radiopharmacological characterization of a 64 Cu-labeled α-MSH analog conjugated with different chelators
  102. Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
  103. Cytocompatible, Injectable, and Electroconductive Soft Adhesives with Hybrid Covalent/Noncovalent Dynamic Network
  104. Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC
  105. Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
  106. Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index
  107. Synthesis and preliminary radiopharmacological characterisation of an 11 C-labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins
  108. Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
  109. Limited importance of EphrinA1–ligand, Src kinase, and focal adhesion kinase in EphA2-mediated regulation of metastasis in Mel-Juso and A375 human melanoma cells
  110. Regulation of A375 melanoma cell adhesion and migration by EphB4 and EphrinB2 – insights from co-culture experiments
  111. Cover Feature: Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (ChemMedChem 3/2019)
  112. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
  113. Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography
  114. One-Pot Cascade Synthesis of Pyrazole Based Isosteres of Valdecoxib by a [3+2] Cycloaddition Sequence and Evaluation of Their Cox Inhibitory Activity
  115. Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
  116. Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo
  117. Synthesis, 18F-labelling and radiopharmacological characterisation of the C-terminal 30mer of Clostridium perfringens enterotoxin as a potential claudin-targeting peptide
  118. Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
  119. Exploring pitfalls of 64Cu-labeled EGFR-targeting peptide GE11 as a potential PET tracer
  120. Causative treatment of acid aspiration induced acute lung injury – Recent trends from animal experiments and critical perspective
  121. From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
  122. Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase
  123. Synthesis, Characterization, and Initial Biological Evaluation of [99m Tc]Tc-Tricarbonyl-labeled DPA-α-MSH Peptide Derivatives for Potential Melanoma Imaging
  124. Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling
  125. Bridging from Brain to Tumor Imaging: (S)-(−)- and (R)-(+)-[18F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice
  126. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
  127. Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments
  128. Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity
  129. Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
  130. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
  131. Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
  132. Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor
  133. Biological characterization of novel nitroimidazole-peptide conjugates in vitr o and in vivo
  134. Novel Tumor Pretargeting System Based on Complementaryl-Configured Oligonucleotides
  135. In Vivo Examination of an Injectable Hydrogel System Crosslinked by Peptide-Oligosaccharide Interaction in Immunocompetent Nude Mice
  136. Human Endothelial Cell Models in Biomaterial Research
  137. Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
  138. Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
  139. A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
  140. Surface charge and particle size determine the metabolic fate of dendritic polyglycerols
  141. The why and how of amino acid analytics in cancer diagnostics and therapy
  142. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection
  143. Development of a18F-labeled Diaryl-Substituted Dihydropyrrolo[3,2,1-hi]indole as Potential Probe for Functional Imaging of Cyclooxygenase-2 with PET
  144. S100 proteins and scavenger receptors: what's going on?
  145. Zwitterionic Polymer-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Low Protein Interaction and High Biocompatibility
  146. Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells
  147. Corrigendum: Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2
  148. Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2
  149. Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review
  150. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells
  151. 177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment
  152. Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitro
  153. Controlled immobilization of His-tagged proteins for protein-ligand interaction experiments using Ni2+-NTA layer on glass surfaces
  154. Gelatin-based Hydrogel Degradation and Tissue Interactionin vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice
  155. Multimodal Somatostatin Receptor Theranostics Using [64Cu]Cu-/[177Lu]Lu-DOTA-(Tyr3)octreotate and AN-238 in a Mouse Pheochromocytoma Model
  156. Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma
  157. 68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika
  158. Development of indazolylpyrimidine derivatives as high-affine EphB4 receptor ligands and potential PET radiotracers
  159. Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors
  160. Copper(II) Cyclam Complexes withN-­Propionic Acid Pendant Arms
  161. Effects of pulmonary acid aspiration on the regional pulmonary blood flow within the first hour after injury: An observational study in rats1
  162. 18F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent
  163. Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes
  164. Synthesis and Biodistribution Studies of 3 H- and 64 Cu-Labeled Dendritic Polyglycerol and Dendritic Polyglycerol Sulfate
  165. Diaryl-Substituted (Dihydro)pyrrolo[3,2,1-hi]indoles, a Class of Potent COX-2 Inhibitors with Tricyclic Core Structure
  166. Reduced pulmonary blood flow in regions of injury 2 hours after acid aspiration in rats
  167. Optical imaging of COX-2: Studies on an autofluorescent 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitor
  168. Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis
  169. Novel indole-based sigma-2 receptor ligands: synthesis, structure–affinity relationship and antiproliferative activity
  170. Biocompatibility and inflammatory response in vitro and in vivo to gelatin-based biomaterials with tailorable elastic properties
  171. In Vivo Fluorescence Imaging and Urinary Monoamines as Surrogate Biomarkers of Disease Progression in a Mouse Model of Pheochromocytoma
  172. Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2
  173. Bispidine Dioxotetraaza Macrocycles: A New Class of Bispidines for 64Cu PET Imaging
  174. Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy
  175. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages
  176. ChemInform Abstract: Tissue Transglutaminase: An Emerging Target for Therapy and Imaging
  177. Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential
  178. 2,3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development
  179. Organotypical vascular model for characterization of radioprotective compounds: Studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors
  180. Synthesis and radiopharmacological evaluation of 64Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator
  181. Tissue transglutaminase: An emerging target for therapy and imaging
  182. Pulmonary Blood Flow Increases in Damaged Regions Directly after Acid Aspiration in Rats
  183. Optimization of Pentadentate Bispidines as Bifunctional Chelators for64Cu Positron Emission Tomography (PET)
  184. Synthesis and Radiopharmacological Characterisation of a Fluorine-18-Labelled Azadipeptide Nitrile as a Potential PET Tracer for in vivo Imaging of Cysteine Cathepsins
  185. Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
  186. Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells
  187. An Efficient Bioorthogonal Strategy Using CuAAC Click Chemistry for Radiofluorinations of SNEW Peptides and the Role of Copper Depletion
  188. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro
  189. 2-Carbaborane-3-phenyl-1H-indoles-Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity
  190. Copper(ii) chemistry of the functionalized macrocycle cyclam tetrapropionic acid
  191. Visualization of cyclooxygenase-2 using a 2,3-diarylsubstituted indole-based inhibitor and confocal laser induced cryofluorescence microscopy at 20K in melanoma cells in vitro
  192. 18F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells
  193. Protein and non-protein biomarkers in melanoma: a critical update
  194. Fluorine-18 Radiolabeling and Radiopharmacological Characterization of a Benzodioxolylpyrimidine-based Radiotracer Targeting the Receptor Tyrosine Kinase EphB4
  195. Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo
  196. Design, Evaluation, and Comparison of Ghrelin Receptor Agonists and Inverse Agonists as Suitable Radiotracers for PET Imaging
  197. Irradiation affects cellular properties and Eph receptor expression in human melanoma cells
  198. Site-selective radiolabeling of peptides by 18F-fluorobenzoylation with [18F]SFB in solution and on solid phase: a comparative study
  199. Cyclin-Dependent Kinases (Cdk) as Targets for Cancer Therapy and Imaging
  200. Specific Targeting of Hypoxic Tumor Tissue with Nitroimidazole-Peptide Conjugates
  201. Synthesis of an 18F-labeled cyclin-dependent kinase-2 inhibitor
  202. Automated radiosynthesis of the thiol-reactive labeling agent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM)
  203. Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells
  204. Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1
  205. A novel tetrabranched neurotensin(8–13) cyclam derivative: Synthesis, 64Cu-labeling and biological evaluation
  206. Synthesis, characterization and biological evaluation of [188Re(N)(cys∼)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals
  207. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors
  208. Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?
  209. S100 proteins in health and disease
  210. Modulation of Adrenal Aldosterone Release by Oxidative Modification of Low-Density Lipoprotein
  211. S100A2 in cancerogenesis: a friend or a foe?
  212. Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
  213. Synthesis of neurotensin(8–13)–phosphopeptide heterodimers via click chemistry
  214. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo
  215. Improved multimodality imaging using alginate molding in xenograft tumor models
  216. Effects of posture on regional pulmonary blood flow in rats as measured by PET
  217. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors
  218. Eph receptors and ephrins: bloody players
  219. Influence of irradiation on metabolism and metastatic potential of B16-F10 melanoma cells
  220. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging
  221. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging
  222. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer
  223. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives
  224. Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging
  225. Erratum
  226. Fluorine-18 labeling of phosphopeptides: A potential approach for the evaluation of phosphopeptide metabolism in vivo
  227. Reduction of Arteriosclerotic Nanoplaque Formation and Size by n-3 Fatty Acids in Patients after Valvular Defect Operation
  228. Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study
  229. Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion
  230. Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor
  231. Radiolabeled Glucocorticoids as Molecular Probes for Imaging Brain Glucocorticoid Receptors by Means of Positron Emission Tomography (PET)
  232. Synthesis and Application of [18F]FDG-Maleimidehexyloxime ([18F]FDG-MHO): A [18F]FDG-Based Prosthetic Group for the Chemoselective18F-Labeling of Peptides and Proteins†
  233. Human S100A12: a novel key player in inflammation?
  234. Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)
  235. Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins—potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo
  236. Glycoxidation of Low Density Lipoprotein in Impaired Glucose Tolerance: Implications for the Pathogenesis of Diabetic Vascular Disease
  237. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability
  238. Modified “4 + 1” Mixed Ligand Technetium-Labeled Fatty Acids for Myocardial Imaging: Evaluation of Myocardial Uptake and Biodistribution
  239. L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo
  240. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo
  241. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance
  242. Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: Comparison of different tumor cells and primary endothelial cells
  243. Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues
  244. Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptors
  245. Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages
  246. Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive reagent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide
  247. Lipid transfer protein activities in subjects with impaired glucose tolerance
  248. Synthesis and Biological Evaluation of a New Type of99mTechnetium-Labeled Fatty Acid for Myocardial Metabolism Imaging
  249. Biodistribution and catabolism of 18F-labeled N-ε-fructoselysine as a model of Amadori products
  250. Positron emission tomography in food sciences
  251. Glucose-Induced Enhancement of Hemin-Catalyzed LDL Oxidation In Vitro and In Vivo
  252. Small animal positron emission tomography in food sciences
  253. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies
  254. Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography
  255. Biodistribution and catabolism of 18F-labelled isopeptide Nɛ-(γ-glutamyl)-L-lysine
  256. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo
  257. Oxidativ modifizierte Lipoproteine und deren Antik�rper bei Patienten mit Antiphospholipidsyndrom und Systemischem Lupus erythematodes
  258. The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells
  259. The protective effects of HDL and its constitutents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL
  260. The effect of garlic on arteriosclerotic nanoplaque formation and size
  261. Analysis of non-protein amino acids as specific markers of low density lipoprotein apolipoprotein B-100 oxidation in human atherosclerotic lesions: the use ofN(O)-ethoxycarbonyl trifluoroethyl ester derivatives and GC-MS1
  262. Analysis of 6-hydroxy-2-aminocaproic acid (HACA) as a specific marker of protein oxidation: The use of N(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry
  263. Measurement of 5-hydroxy-2-aminovaleric acid as a specific marker of metal catalysed oxidation of proline and arginine residues of low density lipoprotein apolipoprotein B-100 in human atherosclerotic lesions
  264. Lack of Association between Serum Paraoxonase 1 Activities and Increased Oxidized Low-Density Lipoprotein Levels in Impaired Glucose Tolerance and Newly Diagnosed Diabetes Mellitus
  265. Analysis of 3-chlorotyrosine as a specific marker of protein oxidation: the use ofN(O,S)-ethoxycarbonyltrifluoroethyl ester derivatives and gas chromatography/mass spectrometry
  266. Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells
  267. In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance
  268. Protective Effects of Native But Not Oxidized High-Density Lipoprotein against Proinflammatory Respiratory Burst Activities of Polymorphonuclear Leukocytes Induced by Hypochlorite-Oxidized Low-Density Lipoprotein
  269. UVB-Induced Conversion of 7-Dehydrocholesterol to 1α,25-Dihydroxyvitamin D3 in an In Vitro Human Skin Equivalent Model
  270. Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy
  271. Different susceptibility to oxidation of proline and arginine residues of apolipoprotein B-100 among subspecies of low density lipoproteins
  272. Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time
  273. Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism
  274. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents
  275. Measurement of 5-Hydroxy-2-aminovaleric Acid as a Specific Marker of Iron-Mediated Oxidation of Proline and Arginine Side-Chain Residues of Low-Density Lipoprotein Apolipoprotein B-100
  276. Urate modifies lipoprotein oxidation
  277. Human secretory group IIA phospholipase A2 is associated with lipid metabolism
  278. Störungen des Lipid- und Lipoproteinstoffwechsels
  279. Metabolic Basis of Low High Density Lipoprotein in Subjects with Impaired Glucose Tolerance
  280. Very Low Density Lipoprotein Overproduction Is Maximally Expressed in Early Insulin Resistant States
  281. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance
  282. Human keratinocyte line HaCaT metabolizes 1α-hydroxyvitamin D3 and vitamin D3 to 1α,25-dihydroxyvitamin D3 (calcitriol)
  283. Determination of Total Homocysteine
  284. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells
  285. Stable isotope ratio analysis of amino acids: the use ofN(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry
  286. Rapid Determination of Total Homocysteine in Human Plasma by Using N(O,S)-Ethoxycarbonyl Ethyl Ester Derivatives and Gas Chromatography–Mass Spectrometry,
  287. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition
  288. Recovery of Cholesterol and Triacylglycerol in Very-Fast Ultracentrifugation of Human Lipoproteins in a Large Range of Concentrations
  289. Very-fast ultracentrifugation of human plasma lipoproteins: influence of the centrifugal field on lipoprotein composition